Systemic Abscopal Effect of Low-dose Radiotherapy (2 Gy x2) against Palatine Tonsil Follicular Lymphoma

被引：2
|
作者：
Togitani, Kazuto [1 ]
Asagiri, Tadashi
Iguchi, Mitsuko
Igawa, Takuro
Yoshino, Tadashi
Kojima, Kensuke
机构：
[1] Kochi Univ, Kochi Med Sch, Dept Hematol, Kochi, Japan
来源：
INTERNAL MEDICINE | 2022年 / 61卷 / 20期
关键词：
Key words; low-dose radiotherapy; abscopal effect; CD5; follicular lymphoma; MARGINAL ZONE; EXPRESSION; RADIATION; PHASE-3; MUM1;
D O I：
10.2169/internalmedicine.8968-21
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A 52-year-old man presented with palatine tonsillar swelling caused by follicular lymphoma. His tumor burden was low, but exacerbation of snoring and dysphagia was observed. Considering the first wave of coronavirus disease 2019 (COVID-19) pandemic, he received palliative 4-Gy irradiation to the tonsils in 2 fractions, which induced partial regression of tonsillar swellings and eradication of the circulating lymphoma cells. We suggest that low-dose radiotherapy triggered an abscopal effect of lymphoma, which allowed the patient time to receive COVID-19 vaccination before starting immunosuppressive chemo-immunotherapy.
引用
收藏
页码：3107 / 3110
页数：4
相关论文
共 50 条
  • [41] Therapeutic responses and predictors of low-dose interleukin-2 in systemic lupus erythematosus
    Miao, M.
    Li, Y.
    Xu, D.
    Zhang, R.
    He, J.
    Sun, X.
    Li, Z.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : 867 - 871
  • [42] SAFETY AND EFFICIENCY OF LOW-DOSE INTERLEUKIN-2 TREATMENT IN SYSTEMIC LUPUS ERYTHEMATOSUS
    He, J.
    Zhang, X.
    Yu, D.
    Li, Z-G.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 1075 - 1076
  • [43] EFFICACY AND SAFETY OF LOW-DOSE IL-2 IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
    Su, Q. Y.
    Luo, J.
    Di, J. K.
    Yin, X. Y.
    Xu, D. N.
    Li, X.
    Wang, C.
    Zhang, S. X.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 640 - 641
  • [44] Low-dose interleukin-2 for the treatment of systemic lupus erythematosus with recurrent rash
    Cheng, Jirong
    He, Miao
    Ma, Di
    Li, Xing
    Peng, Yuanhong
    RHEUMATOLOGY & AUTOIMMUNITY, 2024,
  • [45] Low-dose IL-2 may enhance the effect of vedolizumab
    Lee, Cheng Hiang
    Huang, Sarah
    Hsu, Peter
    Leong, Rupert
    Nanan, Brigitte
    Nanan, Ralph
    SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 2022, 57 (11) : 1404 - 1405
  • [46] RETRACTION: Low-dose radiotherapy (2x2 g) versus low doses and rituximab in the treatment of marginal zone b-cell lymphoma previously untreated (Retraction of Vol 98, art no 106443, 2020)
    Aviles, Agustin
    Cleto, Sergio
    LEUKEMIA RESEARCH, 2022, 118
  • [47] The effect of combining PD-1 agonist and low-dose Interleukin-2 on treating systemic lupus erythematosus
    Wang, Bing
    Chen, Can
    Liu, Xia
    Zhou, Shuang
    Xu, Ting
    Wu, Min
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [48] Low-dose interleukin-2 for the treatment of systemic lupus erythematosus - the Charact-IL-2 trial
    Raeber, M. E.
    Impellizzieri, D.
    Steiner, U.
    Boyman, O.
    SWISS MEDICAL WEEKLY, 2018, 148 : 29S - 29S
  • [49] Local low-dose interleukin-2 induces systemic immunity when combined with radiotherapy of cancer. A pre-clinical study
    Everse, LA
    Renes, IB
    JurgenliemkSchulz, IM
    Rutgers, DH
    Bernsen, MR
    Dullens, HFJ
    DenOtter, W
    Battermann, JJ
    INTERNATIONAL JOURNAL OF CANCER, 1997, 72 (06) : 1003 - 1007
  • [50] Low-dose IL-2 treatment confers anti-inflammatory effect against subarachnoid hemorrhage in mice
    Liu, Jia
    Qi, Biao
    Ye, Yanrong
    Shen, Yun
    Lin, Yufu
    Chen, Yabo
    Ding, Shan
    Ma, Jun
    Chen, Shaozhuang
    HELIYON, 2024, 10 (09)
12345